Your browser doesn't support javascript.
loading
Melatonin: A hypothesis for Kawasaki disease treatment.
Ramos, Eva; Patiño, Paloma; Reiter, Russel J; Gil-Martín, Emilio; López-Muñoz, Francisco; Romero, Alejandro.
Affiliation
  • Ramos E; Department of Pharmacology & Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040 Madrid, Spain.
  • Patiño P; Paediatric Unit, La Paz University Hospital, Paseo de la Castellana 261, 28046 Madrid, Spain.
  • Reiter RJ; Department of Cellular and Structural Biology. University of Texas Health Science Center at San Antonio, USA.
  • Gil-Martín E; Department of Biochemistry, Genetics and Immunology, Biomedical Research Center (CINBIO, "Centro de Investigación de Galicia"), University of Vigo, Vigo, Spain.
  • López-Muñoz F; Faculty of Health, Camilo José Cela University, Villanueva de la Cañada, Madrid, Spain; Neuropsychopharmacology Unit, "Hospital 12 de Octubre" Research Institute, Madrid, Spain.
  • Romero A; Department of Pharmacology & Toxicology, Faculty of Veterinary Medicine, Complutense University of Madrid, 28040 Madrid, Spain. Electronic address: manarome@ucm.es.
Med Hypotheses ; 119: 6-10, 2018 Oct.
Article in En | MEDLINE | ID: mdl-30122493

Full text: 1 Database: MEDLINE Main subject: Melatonin / Mucocutaneous Lymph Node Syndrome Type of study: Guideline Language: En Journal: Med Hypotheses Year: 2018 Type: Article Affiliation country: Spain

Full text: 1 Database: MEDLINE Main subject: Melatonin / Mucocutaneous Lymph Node Syndrome Type of study: Guideline Language: En Journal: Med Hypotheses Year: 2018 Type: Article Affiliation country: Spain